Quarterly report pursuant to Section 13 or 15(d)

LOSS PER SHARE (Tables)

v3.21.1
LOSS PER SHARE (Tables)
3 Months Ended
Feb. 28, 2021
Earnings Per Share [Abstract]  
Schedule of anti-dilutive shares

The following potential common shares, presented based on amounts outstanding at each period end, were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:

 

    For the Three Months Ended
    February 28, 2021     February 29, 2020
Convertible Notes           43,869,127
Series A Preferred Stock     46,366,490      
Warrants     5,323,192       46,435,637
Stock Options     6,870,500       6,889,167
Total     58,560,182       97,193,931